Real-world experience with hypomethylating agents and venetoclax as induction or salvage therapy followed by allogeneic stem cell transplantation in patients with acute myeloid leukemia

被引：0
|
作者：
Rautenberg, C. [1 ]
Stelljes, M. [2 ]
Acker, F. [3 ]
Holtick, U. [4 ]
Jost, E. [5 ]
Ragette, A. [1 ]
Kaivers, J. [1 ]
Tischer, J. [6 ]
Fraccaroli, A. [6 ]
Neuendor, N. [1 ]
Hanoun, M. [1 ]
Schmalbrock, L. K. [7 ]
Braitsch, K. [8 ]
Verbeek, M. [8 ]
Goetze, K. [8 ]
Bug, G. [3 ]
Reinhardt, C. [1 ]
Kroeger, N. [9 ]
Schroeder, T. [1 ]
机构：
[1] Uniklin Essen, Klin Hamatol & Stammzelltransplantat, Essen, Germany
[2] Uniklin Munster, Munster, Germany
[3] Uniklin Frankfurt, Frankfurt, Germany
[4] Uniklin Koln, Cologne, Germany
[5] Uniklin Aachen, Aachen, Germany
[6] LMU Munchen, Munich, Germany
[7] Charite Univ Med Berlin, Dept Hematol Oncol & Canc Immunol, Campus Benjamin Franklin, Berlin, Germany
[8] Klinikum Rechts Der Isar, Munich, Germany
[9] Uniklin Hamburg Eppendorf, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P369
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [1] Venetoclax and Hypomethylating Agents Followed By Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
    Rautenberg, Christina
    Ragette, Anja
    Kaivers, Jennifer
    Neuendorff, Nina
    Hanoun, Maher
    Reinhardt, Hans Christian
    Schroeder, Thomas
    BLOOD, 2022, 140 : 12943 - 12944
  • [2] VENETOCLAX AND HYPOMETHYLATING AGENTS FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Rautenberg, Christina
    Stelljes, Matthias
    Acker, Fabian
    Holtick, Udo
    Jost, Edgar
    Schliemann, Christoph
    Ragette, Anja
    Kaivers, Jennifer
    Neuendorff, Nina
    Hanoun, Maher
    Schmalbrock, Laura K.
    Braitsch, Krishan
    Verbeek, Mareike
    Goetze, Katharina
    Bug, Gesine
    Reinhardt, Christian
    Kroeger, Nicolaus
    Schroeder, Thomas
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 163 - 163
  • [3] HYPOMETHYLATING AGENTS ± DLI AS SALVAGE THERAPY FOR ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION. A REAL LIFE EXPERIENCE
    Lazzarotto, D.
    Candoni, A.
    Fili, C.
    Ventura, G.
    Zannier, M. E.
    Rabassi, N.
    Dubbini, M. V.
    Simeone, E.
    Patriarca, F.
    Fanin, R.
    HAEMATOLOGICA, 2017, 102 : 68 - 69
  • [4] Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia
    Kennedy, Vanessa E.
    Hui, Gavin
    Azenkot, Tali
    Gaut, Daria
    Wieduwilt, Matthew J.
    Oliai, Caspian
    Jonas, Brian A.
    Mittal, Varun
    Logan, Aaron C.
    Muffly, Lori S.
    Mannis, Gabriel N.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : E191 - E194
  • [5] Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation
    Ozturk, C.
    Sahin, U.
    Seval, G. C.
    Bozdag, S. C.
    Toprak, S. K.
    Yuksel, M. K.
    Topcuoglu, P.
    Ozcan, M.
    Gurman, G.
    Ilhan, O.
    Arslan, O.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 335 - 336
  • [6] Real-World Experience of Adults With Acute Myeloid Leukemia on Hypomethylating Agents With or Without Venetoclax at a Comprehensive Cancer Center
    Freeman, Tracelyn
    Williams, Kiersten
    Puto, Marcin
    Waller, Allyson
    McLaughlin, Eric M.
    Blachly, James S.
    Roddy, Julianna
    WORLD JOURNAL OF ONCOLOGY, 2023, 14 (01) : 40 - 50
  • [7] Efficacy of Venetoclax Combination Therapy with Hypomethylating Agents in Patients with Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation
    Mittal, Varun
    Lo, Mimi
    Damon, Lloyd E.
    Gaensler, Karin L.
    Martin, Thomas G., III
    Olin, Rebecca L.
    Smith, Catherine C.
    Logan, Aaron C.
    BLOOD, 2019, 134
  • [8] Hypomethylating Agents and Low-Dose Venetoclax for Relapse Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
    Vigil, Carlos Enrique
    Silverman, Margarida
    Carter, Thomas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S104 - S104
  • [9] Venetoclax, Hypomethylating Agents and Dli for Salvage Treatment of Myeloid Malignancies Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
    Schuler, Esther
    Wagner-Drouet, Eva-Maria
    Ajib, Salem
    Bug, Gesine
    Crysandt, Martina
    Dressler, Sabine
    Hausmann, Andreas
    Heidenreich, Daniela
    Hirschbuehl, Klaus
    Hoepting, Matthias
    Jost, Edgar
    Kaivers, Jennifer
    Klein, Stefan
    Kordelas, Lambros
    Kriege, Oliver
    Mueller, Lutz
    Rautenberg, Christina
    Schaffrath, Judith
    Schmid, Christoph
    Wolff, Daniel
    Haas, Rainer
    Bornhaeuser, Martin
    Schroeder, Thomas
    Kobbe, Guido
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 590 - 591
  • [10] Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia
    Winters, Amanda C.
    Gutman, Jonathan A.
    Purev, Enkhtsetseg
    Nakic, Molly
    Tobin, Jennifer
    Chase, Stephanie
    Kaiser, Jeff
    Lyle, Lindsey
    Boggs, Chelsey
    Halsema, Keri
    Schowinsky, Jeffrey T.
    Rosser, Julie
    Ewalt, Mark D.
    Siegele, Bradford
    Rana, Vishal
    Schuster, Steven
    Abbott, Diana
    Stevens, Brett M.
    Jordan, Craig T.
    Smith, Clayton
    Pollyea, Daniel A.
    BLOOD ADVANCES, 2019, 3 (20) : 2911 - 2919
12345